SelectQuote (SLQT) Upgraded to Strong Buy: What Does It Mean for the Stock?
SelectQuote (SLQT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SLQT - SelectQuote, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$3.00
DETAILS
HIGH:
$3.00
LOW:
$3.00
MEDIAN:
$3.00
CONSENSUS:
$3.00
UPSIDE:
200.00%
Stock News
SelectQuote Announces Participation in Upcoming RBC Global Healthcare Conference on May 20
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, announced today that Chief Financial Officer, Ryan Clement, and Head of Investor Relations, Matt Gunter, will participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026, beginning at approximately 11:00am ET. Management will also be available for 1x1 and small.
Here Is Why Bargain Hunters Would Love Fast-paced Mover SelectQuote (SLQT)
SelectQuote (SLQT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Should Value Investors Buy SelectQuote (SLQT) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
SelectQuote, Inc. (SLQT) Q3 2026 Earnings Call Transcript
SelectQuote, Inc. (SLQT) Q3 2026 Earnings Call Transcript
SelectQuote (SLQT) Beats Q3 Earnings Estimates
SelectQuote (SLQT) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.03 per share a year ago.
SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2026 Results
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the third quarter of fiscal year 2026 of $430.9 million compared to consolidated revenue for the third quarter of fiscal year 2025 of $408.2 million. Consolidated net income for the third quarter of fiscal year 2026 was $40.2 million compared to consolidated net income for the third quarter of fiscal year 2025 of $26.0 million. Finally, consolidated Adjusted EBITDA* for the third quarter of fi.
SelectQuote to Release Fiscal Third Quarter 2026 Earnings on May 5
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing healthcare services platform, today announced it will release its fiscal third quarter 2026 financial results before market open on Tuesday, May 5, 2026. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (May 5, 2026) at 8:30 am ET to discuss the results. We en.
Kuehn Law Encourages Investors of SelectQuote, Inc. to Contact Law Firm
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SelectQuote, Inc. (NYSE: SLQT) breached their fiduciary duties to shareholders.
SelectQuote, Inc. Announces Receipt of Continued Listing Standard Notice from NYSE; Plans to Take Appropriate Actions to Cure
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”) announced today that the Company received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) indicating that the Company is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period. The Company recently reported strong fiscal second quart.
Kuehn Law Encourages Investors of SelectQuote, Inc. to Contact Law Firm
NEW YORK, March 18, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SelectQuote, Inc. (NYSE: SLQT) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at SelectQuote caused the company to misrepresent or fail to disclose that: (1) that the Company was directing Medicare beneficiaries to the plans offered by insurers that best compensated SelectQuote, regardless of the quality or suitability of the insurers' plans; (2) that SelectQuote did not provided unbiased comparison shopping for Medicare Advantage insurance plans; (3) that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers and limit enrollment in competitors' plans; (4) that as a result, SelectQuote had not complied with applicable laws, regulations, and contractual provisions; (5) that SelectQuote was vulnerable to regulatory and legal sanctions as a result of its conduct, including claims that it had violated the False Claims Act; and (6) that, as a result of the foregoing, positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
SelectQuote Announces SelectQuote Local, Adding a New Strategic Growth Channel to Its Industry-Leading Insurance Platform
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced an initiative to expand its reach and complement its existing, telephonic insurance distribution model. SelectQuote Local will leverage the Company's industry-leading marketing, technology, customer service, and carrier relationships to offer consumers its senior health and life ins.
Analyzing SelectQuote (NYSE:SLQT) & World Access (OTCMKTS:WAXS)
World Access (OTCMKTS:WAXS - Get Free Report) and SelectQuote (NYSE: SLQT - Get Free Report) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation. Analyst Ratings This is a breakdown of current ratings
Kuehn Law Encourages Investors of SelectQuote, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - March 6, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SelectQuote, Inc. (NYSE: SLQT) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at SelectQuote caused the company to misrepresent or fail to disclose that: (1) that the Company was directing Medicare beneficiaries to the plans offered by insurers that best compensated SelectQuote, regardless of the quality or suitability of the insurers' plans; (2) that SelectQuote did not provided unbiased comparison shopping for Medicare Advantage insurance plans; (3) that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers and limit enrollment in competitors' plans; (4) that as a result, SelectQuote had not complied with applicable laws, regulations, and contractual provisions; (5) that SelectQuote was vulnerable to regulatory and legal sanctions as a result of its conduct, including claims that it had violated the False Claims Act; and (6) that, as a result of the foregoing, positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
SelectQuote Announces Participation in Upcoming Mizuho Virtual Healthcare Technology Conference on March 5
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, announced today that Tim Danker, Chief Executive Officer, and Ryan Clement, Chief Financial Officer, will participate in Mizuho's 2026 Virtual Healthcare Technology Conference on Thursday, March 5, 2026. Management will be available for 1x1 and small group investor meetings. About SelectQuote Founded in 1985, Sele.
SelectQuote Q2 Earnings Call Highlights
SelectQuote (NYSE: SLQT) management highlighted what it described as a "strong quarter" driven by solid execution during the Medicare Advantage annual enrollment period (AEP), continued growth in its Healthcare Services segment, and recently announced financing and pharmacy benefit manager (PBM) agreements that the company said improve visibility and capital flexibility. At the same time, executives reduced
After Plunging 27.0% in 4 Weeks, Here's Why the Trend Might Reverse for SelectQuote (SLQT)
The heavy selling pressure might have exhausted for SelectQuote (SLQT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
SelectQuote, Inc. (SLQT) Q2 2026 Earnings Call Transcript
SelectQuote, Inc. (SLQT) Q2 2026 Earnings Call Transcript
SelectQuote, Inc. Reports Second Quarter of Fiscal Year 2026 Results
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the second quarter of fiscal year 2026 of $537.1 million compared to consolidated revenue for the second quarter of fiscal year 2025 of $481.1 million. Consolidated net income for the second quarter of fiscal year 2026 was $69.3 million compared to consolidated net income for the second quarter of fiscal year 2025 of $53.2 million. Finally, consolidated Adjusted EBITDA* for the second quarter.
SelectQuote Q2 Earnings Preview: Sell The Medicare Reimbursement News (Rating Downgrade)
SelectQuote is downgraded to sell as Medicare Advantage reimbursement shocks threaten its core business model. SLQT's fundamentals are deteriorating, with Senior segment profitability slipping and commission revenue at risk from insurer belt-tightening. The 2027 Medicare reimbursement rate increase of just 0.09% is far below expectations, likely pressuring insurer and broker margins.
Price Targets
SelectQuote price target lowered to $3 from $4 at Craig-Hallum
$3.00
(was $1.03)
Craig-Hallum
SelectQuote price target lowered to $5 from $6 at RBC Capital
$5.00
(was $1.43)
RBC Capital
RBC Capital Maintains Sector Perform on SelectQuote, Lowers Price Target to $2
$2.00
(was $1.30)
RBC Capital
Citigroup Maintains Neutral on SelectQuote, Lowers Price Target to $1.5
$1.50
(was $1.35)
Citigroup
Piper Sandler Maintains Neutral on SelectQuote, Lowers Price Target to $3
$3.00
(was $2.63)
Piper Sandler